Although no genetic predispositions on NLRP3 have been discovered in AD individuals, NLRP3 and its effector protein caspase-1 were impaired in the lesional skin of AD patients, when compared to healthy controls [40]. This evidence concerns the gene CASP1 and Alzheimer disease.